<DOC>
	<DOCNO>NCT00006198</DOCNO>
	<brief_summary>This clinical trial test safety efficacy drug thalidomide combination procedure call chemoembolization patient inoperable liver cancer . Chemoembolization process chemotherapy instill directly blood vessel feed tumor , blood vessel feed tumor may block . Chemoembolization consist two separate procedure . It do infuse chemotherapy drug doxorubicin hepatic artery liver infuse collagen cut blood supply tumor . A catheter insert various time allow infusion . The objective investigate feasibility potential activity chronic administration thalidomide patient unresectable hepatocellular cancer receive chemoembolization predominant tumor mass . The toxicity thalidomide patient evaluate . Overall safety also assess . Serum level angiogenic cytokine VEGF , bFGF , TNF-a , believe role hepatocellular carcinoma , collect .</brief_summary>
	<brief_title>Chronic Thalidomide Administration Patients Undergoing Chemoembolization Unresectable Hepatocellular Cancer</brief_title>
	<detailed_description />
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>Patients unresectable hepatocellular carcinoma . MRI liver must show discrete tumor nodule . Lesions angiography must hypervascular . Patient must follow minimum lab : ANC &gt; 1200/mm3 ; Hemoglobin &gt; 8 mg/dl ; platelet &gt; 50,000 mm3 ; hepatic transaminase &lt; 5x normal ; bilirubin &lt; 3.0 mg/dl ; creatinine &lt; 1.5 mg/dl . ECOG performance status &gt; 2 . No history prior chemotherapy biologic therapy hepatocellular carcinoma . No history malignancy curatively resect basal cell carcinoma skin carcinoma situ cervix . Patients must pregnant lactating . Sexually active men woman childbearing age must use adequate contraception . All patient must understand potential severe birth defect thalidomide must able follow instruction avoid conception take thalidomide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2004</verification_date>
</DOC>